Cargando…
Glutathione-responsive and -exhausting metal nanomedicines for robust synergistic cancer therapy
Due to their rapid and uncontrolled proliferation, cancer cells are characterized by overexpression of glutathione (GSH), which impairs reactive oxygen species (ROS)-based therapy and weakens the chemotherapeutic agent-induced toxification. Extensive efforts have been made in the past few years to i...
Autores principales: | Liu, Peng, Hao, Lu, Liu, Min, Hu, Shuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036587/ https://www.ncbi.nlm.nih.gov/pubmed/36970628 http://dx.doi.org/10.3389/fbioe.2023.1161472 |
Ejemplares similares
-
Dual Drug Loaded, pH-Sensitive Metal-Organic Particles for Synergistic Cancer Therapy
por: Wu, Shichao, et al.
Publicado: (2022) -
Nanomedicine for the Diagnosis and Therapy of COVID-19
por: Wang, Yingruo, et al.
Publicado: (2021) -
Nanomedicine for Imaging and Therapy of Pancreatic Adenocarcinoma
por: Brachi, Giulia, et al.
Publicado: (2019) -
Editorial: Microenvironmental stimuli-responsive nanomedicine for biomedical application
por: Xia, Donglin, et al.
Publicado: (2023) -
Mitochondria-Targeted Nanomedicine for Enhanced Efficacy of Cancer Therapy
por: Gao, Yan, et al.
Publicado: (2021)